KLOTEN, Switzerland, Jan. 11, 2006 (PRIMEZONE) -- Nobel Biocare will introduce a new continuing and post-graduate education program in a series of 17 training and education conferences on four continents around the world. The "Nobel Biocare World Tour 2006" will start on 9 March in Frankfurt and end on 18 November in Barcelona. Nobel Biocare expects around 30,000 participants to attend these training and education events. Heliane Canepa, President and CEO for Nobel Biocare said: "From our close collaboration with dental professionals around the world, we know that this type of knowledge transfer among dentists and industry addresses a large need."
In June 2005, Nobel Biocare conducted its second World Conference, a bi-annual Training and Education for dental professionals in Las Vegas. Heliane Canepa said, "We were overwhelmed with the echo of the event." Around 6,000 professionals from over 70 countries participated at the four-day conference.
The feedback from participants and the company's own assessment swiftly led to the decision to launch a worldwide training and education program -- based on the same concept. Canepa said, "Together we want to become better -- for the benefit of the patients."
The Nobel Biocare World Tour 2006 is a completely new format. It will bring together world-leading experts in implant and esthetic dentistry with local experts and conference attendees to share their knowledge in state-of-the-art patient treatments.
Live cases transmitted via satellite, including implant surgeries and esthetic restorations, will demonstrate the latest preferred patient treatment options. Additionally, hands-on and in-depth training for all levels of dental professionals will be included.
Nobel Biocare will also present the latest research and clinical findings from its pipeline of products and solutions. Each conference will include an update on the company's research into the development of a bone inductive implant based upon the TiUnite(tm) technology and the Bone Morphogenetic Protein-2 (rhBMP-2). Canepe said, "This new technology has the potential to dramatically reduce, or even eliminate, the need for invasive and time-consuming bone grafting procedures."
Dates for the World Tour 2006:
Frankfurt, Germany March 9 -- 11, 2006 Baltimore, Maryland, USA April 1 -- 3, 2006 Sun City, South Africa April 9 -- 11, 2006 Mumbai, India April 21 -- 23, 2006 Malmo, Sweden April 26 -- 28, 2006 Phoenix, Arizona, USA May 4 -- 6, 2006 Tokyo, Japan May 19 -- 21, 2006 Paris, France June 14 -- 16, 2006 Sydney, Australia August 2 -- 4, 2006 Sao Paolo, Brazil August 16 -- 18, 2006 Hong Kong, China September 3 -- 5, 2006 Maastricht, The Netherlands September 7 -- 9, 2006 London, United Kingdom September 14 -- 16, 2006 Dresden, Germany October 19 -- 21, 2006 Rimini, Italy October 26 -- 28, 2006 Montreal, Quebec, Canada November 2 -- 4, 2006 Barcelona, Spain November 16 -- 18, 2006
More information about the World Tour 2006 is available on www.nobelbiocare.com
NOBEL BIOCARE HOLDING AG
Disclaimer:
This release may contain forward-looking statements including, but not limited to, projections of future performance of materials and products, financial conditions, results of operations and cash flows, containing risks and uncertainties. These statements are subject to change based on unknown risks and other factors that could cause the actual results or performance to differ materially from the statements made herein.
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its brands Branemark System(r), NobelSpeedy(tm), NobelReplace(tm), NobelPerfect(r), NobelDirect(r), Replace(r) Select, (dental implants) and Procera(r) (individualized dental prosthetics). Nobel Biocare is a one-stop shop for restorative esthetic dentistry, offering a wide range of innovative Crown and Bridge and Implant products, as well as training and education and clinically documented treatment concepts. Nobel Biocare has some 1600 employees and recorded revenue of EUR 388 million in 2004. The company is domiciled in Zurich, Switzerland with headquarters in Zurich and in Gothenburg, Sweden. Production takes place at four production sites located in Sweden and the USA. Nobel Biocare has direct sales organizations in 29 countries. The shares of the parent company Nobel Biocare Holding AG are listed on the SWX Swiss Exchange and on the Stockholm Stock Exchange, Sweden.